RSS-Feed abonnieren
DOI: 10.1055/s-0043-102577
Morphologische Hornhautveränderungen nach Crosslinking bei Keratokonus
Morphologic Corneal Changes after Crosslinking for KeratoconusPublikationsverlauf
eingereicht 21. Dezember 2016
akzeptiert 24. Januar 2017
Publikationsdatum:
03. Mai 2017 (online)
Zusammenfassung
Der Keratokonus ist eine relativ häufige (1 : 2000), meist bilateral auftretende Erkrankung, die zu einer Verdünnung, Veränderung der biochemischen und biomechanischen Struktur sowie Vorwölbung der Hornhaut führt. Seit mehr als 10 Jahren steht das Crosslinking als therapeutisches Verfahren für den progredienten Keratokonus zur Verfügung. Dabei wird mittels Riboflavin und UVA-Bestrahlung eine Verfestigung der Quervernetzung der Kollagenfasern in den vorderen 300 µm des Hornhautstromas erreicht. Es ist als wirksam und komplikationsarm beschrieben worden, sofern entsprechende Protokolle und Indikationen eingehalten werden. Diese Übersicht beinhaltet die physiologischen und pathologischen morphologischen Veränderungen der Hornhaut vor und nach Crosslinking bei Keratokonus. Die verfügbare Literatur wird aufgearbeitet und um eigene Beobachtungen und Erfahrungen, basierend auf histopathologischen Untersuchungen, ergänzt.
Abstract
Keratoconus is a relatively common (1 : 2000) bilateral disease leading to a change in biochemical and biomechanical corneal structure as well as thinning and ectasia. For more than 10 years, crosslinking has been a therapeutic option in cases of progression. Using riboflavin and UVA-radiation, the anterior corneal stroma (300 µm) gets stiffened by crosslinking of collagen fibers. When protocols and limitations are adhered, the procedure is described to be effective and of low-risk. This review gives an overview about physiologic and pathologic changes in keratoconic corneas before and after crosslinking. Based on histopathologic examination, the current knowledge in published literature is reviewed and is complemented by our own investigations.
-
Literatur
- 1 Nottingham J. Practical observations on conical cornea: and on the short sight, and other defects of vision connected with it. London, Liverpool: John Churchill, Deighton & Laughton; 1854
- 2 Andreassen TT, Simonsen AH, Oxlund H. Biomechanical properties of keratoconus and normal corneas. Exp Eye Res 1980; 31: 435-441
- 3 Wollensak J, Buddecke E. Biochemical studies on human corneal proteoglycans – a comparison of normal and keratoconic eyes. Graefes Arch Clin Exp Ophthalmol 1990; 228: 517-523
- 4 Meek KM, Tuft SJ, Huang Y. et al. Changes in collagen orientation and distribution in keratoconus corneas. Invest Ophthalmol Vis Sci 2005; 46: 1948-1956
- 5 Rehany U, Lahav M, Shoshan S. Collagenolytic activity in keratoconus. Ann Ophthalmol 1982; 14: 751-754
- 6 Sawaguchi S, Twining SS, Yue BY. et al. Alpha-1 proteinase inhibitor levels in keratoconus. Exp Eye Res 1990; 50: 549-554
- 7 Sawaguchi S, Yue BY, Sugar J. et al. Lysosomal enzyme abnormalities in keratoconus. Arch Ophthalmol 1989; 107: 1507-1510
- 8 Sawaguchi S, Yue BY, Chang I. et al. Proteoglycan molecules in keratoconus corneas. Invest Ophthalmol Vis Sci 1991; 32: 1846-1853
- 9 Sawaguchi S, Fukuchi T, Abe H. et al. Three-dimensional scanning electron microscopic study of keratoconus corneas. Arch Ophthalmol 1998; 116: 62-68
- 10 Sawaguchi S, Twining SS, Yue BY. et al. Alpha 2-macroglobulin levels in normal human and keratoconus corneas. Invest Ophthalmol Vis Sci 1994; 35: 4008-4014
- 11 Zhou L, Sawaguchi S, Twining SS. et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci 1998; 39: 1117-1124
- 12 Kao WW, Vergnes JP, Ebert J. et al. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys Res Commun 1982; 107: 929-936
- 13 Daxer A, Fratzl P. Collagen fibril orientation in the human corneal stroma and its implication in keratoconus. Invest Ophthalmol Vis Sci 1997; 38: 121-129
- 14 Radner W, Zehetmayer M, Skorpik C. et al. Altered organization of collagen in the apex of keratoconus corneas. Ophthalmic Res 1998; 30: 327-332
- 15 Wisse RPL, Kuiper JJW, Gans R. et al. Cytokine expression in keratoconus and its corneal microenvironment: a systematic review. Ocul Surf 2015; 13: 272-283
- 16 Davidson AE, Hayes S, Hardcastle AJ. et al. The pathogenesis of keratoconus. Eye (Lond) 2014; 28: 189-195
- 17 Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 1986; 101: 267-273
- 18 Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998; 42: 297-319
- 19 Gomes JAP, Tan D, Rapuano CJ. et al. Global consensus on keratoconus and ectatic diseases. Cornea 2015; 34: 359-369
- 20 Bykhovskaya Y, Margines B, Rabinowitz YS. Genetics in keratoconus: where are we?. Eye Vis (Lond) 2016; 3: 16
- 21 Hallerman W, Wilson E. Genetische Betrachtungen über den Keratokonus. Klin Monatsbl Augenheilkd 1977; 170: 906-908
- 22 Gordon-Shaag A, Millodot M, Shneor E. et al. The genetic and environmental factors for keratoconus. Biomed Res Int 2015; 2015: 795738
- 23 Cullen JF, Butler HG. Mongolism (Downʼs syndrome) and keratokonus. Br J Ophthalmol 1963; 47: 321-330
- 24 Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 1984; 28: 293-322
- 25 Zadnik K, Barr JT, Edrington TB. et al. Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) study. Invest Ophthalmol Vis Sci 1998; 39: 2537-2546
- 26 Seiler T, Huhle S, Spoerl E. et al. Manifest diabetes and keratoconus: a retrospective case-control study. Graefes Arch Clin Exp Ophthalmol 2000; 238: 822-825
- 27 Sady C, Khosrof S, Nagaraj R. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochem Biophys Res Commun 1995; 214: 793-797
- 28 Spoerl E, Raiskup-Wolf F, Kuhlisch E. et al. Cigarette smoking is negatively associated with keratoconus. J Refract Surg 2008; 24: S737-S740
- 29 Parker JS, van Dijk K, Melles GRJ. Treatment options for advanced keratoconus: a review. Surv Ophthalmol 2015; 60: 459-480
- 30 Gore DM, Shortt AJ, Allan BD. New clinical pathways for keratoconus. Eye (Lond) 2013; 27: 329-339
- 31 Downie LE, Lindsay RG. Contact lens management of keratoconus. Clin Exp Optom 2015; 98: 299-311
- 32 Godefrooij DA, Boom K, Soeters N. et al. Predictors for treatment outcomes after corneal crosslinking for keratoconus: a validation study. Int Ophthalmol 2016; DOI: 10.1007/s10792-016-0262-z.
- 33 Mastropasqua L. Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives. Eye Vis (Lond) 2015; 2: 19
- 34 Lang S, Reinhard T. Crosslinking bei Keratokonus. Klin Monatsbl Augenheilkd 2016; 233: 713-716
- 35 Sorkin N, Varssano D. Corneal collagen crosslinking: a systematic review. Ophthalmologica 2014; 232: 10-27
- 36 Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003; 135: 620-627
- 37 Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 2006; 17: 356-360
- 38 Spoerl E, Mrochen M, Sliney D. et al. Safety of UVA-riboflavin cross-linking of the cornea. Cornea 2007; 26: 385-389
- 39 Wollensak G, Spörl E, Reber F. et al. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res 2003; 35: 324-328
- 40 Wollensak G, Spoerl E, Reber F. et al. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. Eye (Lond) 2004; 18: 718-722
- 41 Wollensak G, Aurich H, Pham D-T. et al. Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A. J Cataract Refract Surg 2007; 33: 516-521
- 42 Mencucci R, Mazzotta C, Rossi F. et al. Riboflavin and ultraviolet A collagen crosslinking: in vivo thermographic analysis of the corneal surface. J Cataract Refract Surg 2007; 33: 1005-1008
- 43 Tabibian D, Mazzotta C, Hafezi F. PACK-CXL: Corneal cross-linking in infectious keratitis. Eye Vis (Lond) 2016; 3: 11
- 44 Seiler TG, Schmidinger G, Fischinger I. et al. Komplikationen der Vernetzung der Hornhaut. Ophthalmologe 2013; 110: 639-644
- 45 Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 2009; 35: 1358-1362
- 46 Kymes SM, Walline JJ, Zadnik K. et al. Changes in the quality-of-life of people with keratoconus. Am J Ophthalmol 2008; 145: 611-617
- 47 Maeno A, Naor J, Lee HM. et al. Three decades of corneal transplantation: indications and patient characteristics. Cornea 2000; 19: 7-11
- 48 Wahrendorf I. Leben mit Keratokonus. Klin Monatsbl Augenheilkd 2006; 223: 877-888
- 49 Duncan JK, Belin MW, Borgstrom M. Assessing progression of keratoconus: novel tomographic determinants. Eye Vis (Lond) 2016; 3: 6
- 50 Maguire LI, Meyer RF. Ectatic corneal Degenerations. In: Kaufman HE, Barron BA, McDonald MB, Waltman SR. eds. The Cornea. New York: Churchill Livingstone; 1988: 485-510
- 51 Pouliquen Y. Doyne lecture keratoconus. Eye (Lond) 1987; 1: 1-14
- 52 Pouliquen Y, DʼHermies F, Puech M. et al. Acute corneal edema in pellucid marginal degeneration or acute marginal keratoconus. Cornea 1987; 6: 169-174
- 53 Sung H-W, Chang W-H, Ma C-Y. et al. Crosslinking of biological tissues using genipin and/or carbodiimide. J Biomed Mater Res A 2003; 64: 427-438
- 54 Chan BP, So K-F. Photochemical crosslinking improves the physicochemical properties of collagen scaffolds. J Biomed Mater Res A 2005; 75: 689-701
- 55 Cannon DJ, Davison PF. Aging, and crosslinking in mammlian collagen. Exp Aging Res 1977; 3: 87-105
- 56 Cannon DJ, Foster CS. Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci 1978; 17: 63-65
- 57 Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf 2013; 11: 65-74
- 58 Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res 1998; 66: 97-103
- 59 Spoerl E, Seiler T. Techniques for stiffening the cornea. J Refract Surg 1999; 15: 711-713
- 60 Spörl E, Huhle M, Kasper M. et al. Erhöhung der Festigkeit der Hornhaut durch Vernetzung. Ophthalmologe 1997; 94: 902-906
- 61 Spörl E, Schreiber J, Hellmund K. et al. Studies on the stabilization of the cornea in rabbits. Ophthalmologe 2000; 97: 203-206
- 62 Spoerl E, Wollensak G, Dittert D-D. et al. Thermomechanical behavior of collagen-cross-linked porcine cornea. Ophthalmologica 2004; 218: 136-140
- 63 Spörl E, Raiskup-Wolf F, Pillunat LE. Biophysikalische Grundlagen der Kollagenvernetzung. Klin Monatsbl Augenheilkd 2008; 225: 131-137
- 64 Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 2004; 29: 35-40
- 65 Kolli S, Aslanides IM. Safety and efficacy of collagen crosslinking for the treatment of keratoconus. Expert Opin Drug Saf 2010; 9: 949-957
- 66 Beshtawi IM, OʼDonnell C, Radhakrishnan H. Biomechanical properties of corneal tissue after ultraviolet-A-riboflavin crosslinking. J Cataract Refract Surg 2013; 39: 451-462
- 67 Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. Part II. Clinical indications and results. Ocul Surf 2013; 11: 93-108
- 68 Xie J, Xu G, Wang J. et al. Steady-state motion visual evoked potentials produced by oscillating Newtonʼs rings: implications for brain-computer interfaces. PLoS One 2012; 7: e39707
- 69 Farjadnia M, Naderan M. Corneal cross-linking treatment of keratoconus. Oman J Ophthalmol 2015; 8: 86-91
- 70 Li Z, Jhanji V, Tao X. et al. Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol 2013; 97: 669-671
- 71 Anwar HM, El-Danasoury AM, Hashem AN. Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol 2011; 5: 1277-1280
- 72 Makdoumi K, Mortensen J, Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea 2010; 29: 1353-1358
- 73 Morén H, Malmsjö M, Mortensen J. et al. Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 2010; 29: 102-104
- 74 Micelli Ferrari T, Leozappa M, Lorusso M. et al. Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol 2009; 19: 295-297
- 75 Kymionis G, Portaliou D. Corneal crosslinking with riboflavin and UVA for the treatment of keratoconus. J Cataract Refract Surg 2007; 33: 1143-1144
- 76 Kohlhaas M. Kollagen-Crosslinking mit Riboflavin und UVA-Licht beim Keratokonus. Ophthalmologe 2008; 105: 785-796
- 77 Daxer A, Mahmoud HA, Venkateswaran RS. Corneal crosslinking and visual rehabilitation in keratoconus in one session without epithelial debridement: new technique. Cornea 2010; 29: 1176-1179
- 78 Rechichi M, Mazzotta C, Daya S. et al. Intraoperative OCT pachymetry in patients undergoing dextran-free riboflavin UVA accelerated corneal collagen crosslinking. Curr Eye Res 2016; 41: 1310-1315
- 79 Aldahlawi NH, Hayes S, OʼBrart DPS. et al. Enzymatic resistance of corneas crosslinked using riboflavin in conjunction with low energy, high energy, and pulsed UVA irradiation modes. Invest Ophthalmol Vis Sci 2016; 57: 1547-1552
- 80 Mazzotta C, Traversi C, Caragiuli S. et al. Pulsed vs. continuous light accelerated corneal collagen crosslinking: in vivo qualitative investigation by confocal microscopy and corneal OCT. Eye (Lond) 2014; 28: 1179-1183
- 81 Mazzotta C, Traversi C, Paradiso AL. et al. Pulsed light accelerated crosslinking versus continuous light accelerated crosslinking: one-year results. J Ophthalmol 2014; 2014: 604731
- 82 Moramarco A, Iovieno A, Sartori A. et al. Corneal stromal demarcation line after accelerated crosslinking using continuous and pulsed light. J Cataract Refract Surg 2015; 41: 2546-2551
- 83 Mastropasqua L, Lanzini M, Curcio C. et al. Structural modifications and tissue response after standard epi-off and iontophoretic corneal crosslinking with different irradiation procedures. Invest Ophthalmol Vis Sci 2014; 55: 2526-2533
- 84 Torricelli AAM, Ford MR, Singh V. et al. BAC-EDTA transepithelial riboflavin-UVA crosslinking has greater biomechanical stiffening effect than standard epithelium-off in rabbit corneas. Exp Eye Res 2014; 125: 114-117
- 85 Rush SW, Rush RB. Epithelium-off versus transepithelial corneal collagen crosslinking for progressive corneal ectasia: a randomised and controlled trial. Br J Ophthalmol 2016; DOI: 10.1136/bjophthalmol-2016-308914.
- 86 Lombardo M, Serrao S, Carbone G. et al. Corneal light backscattering after transepithelial corneal crosslinking using iontophoresis in donor human corneal tissue. J Cataract Refract Surg 2015; 41: 635-643
- 87 Shalchi Z, Wang X, Nanavaty MA. Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus. Eye (Lond) 2015; 29: 15-29
- 88 Cassagne M, Laurent C, Rodrigues M. et al. Iontophoresis transcorneal delivery technique for transepithelial corneal collagen crosslinking with riboflavin in a rabbit model. Invest Ophthalmol Vis Sci 2016; 57: 594-603
- 89 Bouheraoua N, Jouve L, El Sanharawi M. et al. Optical coherence tomography and confocal microscopy following three different protocols of corneal collagen-crosslinking in keratoconus. Invest Ophthalmol Vis Sci 2014; 55: 7601-7609
- 90 Filippello M, Stagni E, OʼBrart D. Transepithelial corneal collagen crosslinking: bilateral study. J Cataract Refract Surg 2012; 38: 283-291
- 91 Chan CC, Squissato V. Keratoconus and crosslinking: pharmacokinetic considerations. Expert Opin Drug Metab Toxicol 2013; 9: 1613-1624
- 92 Çerman E, Toker E, Ozarslan Ozcan D. Transepithelial versus epithelium-off crosslinking in adults with progressive keratoconus. J Cataract Refract Surg 2015; 41: 1416-1425
- 93 Bouheraoua N, Jouve L, Borderie V. et al. Three different protocols of corneal collagen crosslinking in keratoconus: conventional, accelerated and iontophoresis. J Vis Exp 2015; DOI: 10.3791/53119.
- 94 Baiocchi S, Mazzotta C, Cerretani D. et al. Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium. J Cataract Refract Surg 2009; 35: 893-899
- 95 Spadea L, Mencucci R. Transepithelial corneal collagen cross-linking in ultrathin keratoconic corneas. Clin Ophthalmol 2012; 6: 1785-1792
- 96 Bikbova G, Bikbov M. Standard corneal collagen crosslinking versus transepithelial iontophoresis-assisted corneal crosslinking, 24 months follow-up: randomized control trial. Acta Ophthalmol 2016; 94: e600-e606
- 97 Lombardo M, Serrao S, Rosati M. et al. Biomechanical changes in the human cornea after transepithelial corneal crosslinking using iontophoresis. J Cataract Refract Surg 2014; 40: 1706-1715
- 98 Caporossi A, Mazzotta C, Paradiso AL. et al. Transepithelial corneal collagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg 2013; 39: 1157-1163
- 99 Ozmen MC, Hondur A, Yilmaz G. et al. A histological study of rabbit corneas after transepithelial corneal crosslinking using partial epithelial photoablation or ethanol treatment. Int J Ophthalmol 2014; 7: 959-963
- 100 De Bernardo M, Capasso L, Tortori A. et al. Trans epithelial corneal collagen crosslinking for progressive keratoconus: 6 months follow up. Cont Lens Anterior Eye 2014; 37: 438-441
- 101 Nawaz S, Gupta S, Gogia V. et al. Trans-epithelial versus conventional corneal collagen crosslinking: A randomized trial in keratoconus. Oman J Ophthalmol 2015; 8: 9-13
- 102 Wollensak G, Wilsch M, Spoerl E. et al. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea 2004; 23: 503-507
- 103 Hayes S, OʼBrart DP, Lamdin LS. et al. Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg 2008; 34: 657-661
- 104 Schmidinger G, Pachala M, Prager F. Pachymetry changes during corneal crosslinking: effect of closed eyelids and hypotonic riboflavin solution. J Cataract Refract Surg 2013; 39: 1179-1183
- 105 Wand K, Neuhann R, Ullmann A. et al. Riboflavin-UV – a crosslinking for fixation of biosynthetic corneal collagen implants. Cornea 2015; 34: 544-549
- 106 Rosenblat E, Hersh PS. Intraoperative corneal thickness change and clinical outcomes after corneal collagen crosslinking: Standard crosslinking versus hypotonic riboflavin. J Cataract Refract Surg 2016; 42: 596-605
- 107 Hirji N, Sykakis E, Lam FC. et al. Corneal collagen crosslinking for keratoconus or corneal ectasia without epithelial debridement. Eye (Lond) 2015; 29: 764-768
- 108 Hafezi F, Mrochen M, Iseli HP. et al. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J Cataract Refract Surg 2009; 35: 621-624
- 109 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte Nr. 436: UV-Vernetzung mit Riboflavin bei Keratokonus Köln (2016). Im Internet: https://www.iqwig.de/download/N15-05_Abschlussbericht_1-1_Hornhautvernetzung-bei-Keratokonus.pdf Stand: 09.02.2017
- 110 Lang SJ, Messmer EM, Geerling G. et al. Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus. BMC Ophthalmol 2015; 15: 78
- 111 Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg 2011; 37: 149-160
- 112 Reidy J. Treatment of keratoconus using collagen cross-linking (2012). Im Internet: https://clinicaltrials.gov/ct2/show/NCT00841386 Stand: 07.02.2017
- 113 OʼBrart DPS, Chan E, Samaras K. et al. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus. Br J Ophthalmol 2011; 95: 1519-1524
- 114 Wittig-Silva C, Chan E, Islam FMA. et al. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results. Ophthalmology 2014; 121: 812-821
- 115 Seyedian MA, Aliakbari S, Miraftab M. et al. Corneal collagen cross-linking in the treatment of progressive keratoconus: a randomized controlled contralateral eye study. Middle East Afr J Ophthalmol 2015; 22: 340-345
- 116 Sharma N, Suri K, Sehra SV. et al. Collagen cross-linking in keratoconus in Asian eyes: visual, refractive and confocal microscopy outcomes in a prospective randomized controlled trial. Int Ophthalmol 2015; 35: 827-832
- 117 Hashemi H, Fotouhi A, Miraftab M. et al. Short-term comparison of accelerated and standard methods of corneal collagen crosslinking. J Cataract Refract Surg 2015; 41: 533-540
- 118 Beckman Rehnman J, Behndig A, Hallberg P. et al. Initial results from mechanical compression of the cornea during crosslinking for keratoconus. Acta Ophthalmol 2014; 92: 644-649
- 119 Razmjoo H, Rahimi B, Kharraji M. et al. Corneal haze and visual outcome after collagen crosslinking for keratoconus: A comparison between total epithelium off and partial epithelial removal methods. Adv Biomed Res 2014; 3: 221
- 120 Sherif AM. Accelerated versus conventional corneal collagen cross-linking in the treatment of mild keratoconus: a comparative study. Clin Ophthalmol 2014; 8: 1435-1440
- 121 Kanellopoulos J. Long term results of a prospective randomized bilateral eye comparison trial of higher fluence, shorter duration ultraviolet A radiation, and riboflavin collagen cross linking for progressive keratoconus. Clin Ophthalmol 2012; 6: 97
- 122 Ozgurhan EB, Sezgin Akcay BI, Yildirim Y. et al. Evaluation of corneal stromal demarcation line after two different protocols of accelerated corneal collagen cross-linking procedures using anterior segment optical coherence tomography and confocal microscopy. J Ophthalmol 2014; 2014: 981893 DOI: 10.1155/2014/981893
- 123 Hashemian H, Jabbarvand M, Khodaparast M. et al. Evaluation of corneal changes after conventional versus accelerated corneal cross-linking: a randomized controlled trial. J Refract Surg 2014; 30: 837-842
- 124 Stojanovic A, Zhou W, Utheim TP. Corneal collagen cross-linking with and without epithelial removal: a contralateral study with 0.5 % hypotonic riboflavin solution. Biomed Res Int 2014; 2014: 619398 DOI: 10.1155/2014/619398
- 125 Soeters N, Wisse RPL, Godefrooij DA. et al. Transepithelial versus epithelium-off corneal cross-linking for the treatment of progressive keratoconus: a randomized controlled trial. Am J Ophthalmol 2015; 159: 821-828.e3
- 126 Rossi S, Orrico A, Santamaria C. et al. Standard versus trans-epithelial collagen cross-linking in keratoconus patients suitable for standard collagen cross-linking. Clin Ophthalmol 2015; 9: 503-509
- 127 Al Fayez MF, Alfayez S, Alfayez Y. Transepithelial versus epithelium-off corneal collagen cross-linking for progressive keratoconus: a prospective randomized controlled trial. Cornea 2015; 34 (Suppl. 10) S53-S56
- 128 Acar BT, Utine CA, Ozturk V. et al. Can the effect of transepithelial corneal collagen cross-linking be improved by increasing the duration of topical riboflavin application? An in vivo confocal microscopy study. Eye Contact Lens 2014; 40: 207-212
- 129 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Dokumentation und Würdigung der Anhörung zum Vorbericht N15-05, Köln (2016). Im Internet: https://www.iqwig.de/download/N15-05_DWA-VB_Hornhautvernetzung-bei-Keratokonus.pdf Stand: 09.02.2017
- 130 Mazzotta C, Hafezi F, Kymionis G. et al. In vivo confocal microscopy after corneal collagen crosslinking. Ocul Surf 2015; 13: 298-314
- 131 Xia Y, Liu B, Fan Z. et al. Corneal collagen fibril changes after ultraviolet a/riboflavin corneal crosslinking. Cornea 2014; 33: 56-59
- 132 El-Raggal TM. Riboflavin-ultraviolet A corneal cross-linking for keratoconus. Middle East Afr J Ophthalmol 2009; 16: 256-259
- 133 Greenstein SA, Fry KL, Bhatt J. et al. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg 2010; 36: 2105-2114
- 134 Knappe S, Stachs O, Zhivov A. et al. Results of confocal microscopy examinations after collagen cross-linking with riboflavin and UVA light in patients with progressive keratoconus. Ophthalmologica 2011; 225: 95-104
- 135 Salomão MQ, Chaurasia SS, Sinha-Roy A. et al. Corneal wound healing after ultraviolet-A/riboflavin collagen cross-linking: a rabbit study. J Refract Surg 2011; 27: 401-407
- 136 Kymionis GD, Tsoulnaras KI, Grentzelos MA. et al. Corneal stroma demarcation line after standard and high-intensity collagen crosslinking determined with anterior segment optical coherence tomography. J Cataract Refract Surg 2014; 40: 736-740
- 137 Tomita M, Mita M, Huseynova T. Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg 2014; 40: 1013-1020
- 138 Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea 2006; 25: 1057-1059
- 139 Doors M, Tahzib NG, Eggink FA. et al. Use of anterior segment optical coherence tomography to study corneal changes after collagen cross-linking. Am J Ophthalmol 2009; 148: 844-851.e2
- 140 Asri D, Touboul D, Fournié P. et al. Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refract Surg 2011; 37: 2137-2143
- 141 Kampik D, Koch M, Kampik K. et al. Kollagenvernetzung mittels Riboflavin und UV-A-Strahlung (CXL) bei Keratokonus: Zwei-Jahres-Ergebnisse. Klin Monatsbl Augenheilkd 2011; 228: 525-530
- 142 Ivarsen A, Hjortdal J. Collagen cross-linking for advanced progressive keratoconus. Cornea 2013; 32: 903-906
- 143 Pecorella I, Appolloni R, Tiezzi A. et al. Histological findings in a failed corneal riboflavin-UVA collagen cross-linking performed for progressive keratoconus. Cornea 2013; 32: 191-195
- 144 Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg 2009; 25: S824-S828
- 145 Kato N, Konomi K, Saiki M. et al. Deep stromal opacity after corneal cross-linking. Cornea 2013; 32: 895-898
- 146 Messmer EM, Meyer P, Herwig MC. et al. Morphological and immunohistochemical changes after corneal cross-linking. Cornea 2013; 32: 111-117
- 147 Javadi M-A, Feizi S. Sterile keratitis following collagen crosslinking. J Ophthalmic Vis Res 2014; 9: 510
- 148 Koppen C, Vryghem JC, Gobin L. et al. Keratitis and corneal scarring after UVA/riboflavin cross-linking for keratoconus. J Refract Surg 2009; 25: S819-S823
- 149 Mangioris GF, Papadopoulou DN, Balidis MO. et al. Corneal infiltrates after corneal collagen cross-linking. J Refract Surg 2010; 26: 609-611
- 150 Arora R, Jain P, Gupta D. et al. Sterile keratitis after corneal collagen crosslinking in a child. Cont Lens Anterior Eye 2012; 35: 233-235
- 151 Rodríguez-Ausín P, Gutiérrez-Ortega R, Arance-Gil A. et al. Keratopathy after cross-linking for keratoconus. Cornea 2011; 30: 1051-1053
- 152 Ghanem RC, Netto MV, Ghanem VC. et al. Peripheral sterile corneal ring infiltrate after riboflavin-UVA collagen cross-linking in keratoconus. Cornea 2012; 31: 702-705
- 153 Camesasca FI, Vinciguerra P, Seiler T. Bilateral ring-shaped intrastromal opacities after corneal cross-linking for keratoconus. J Refract Surg 2011; 27: 913-915
- 154 Thorsrud A, Nicolaissen B, Drolsum L. Corneal collagen crosslinking in vitro: inhibited regeneration of human limbal epithelial cells after riboflavin-ultraviolet-A exposure. J Cataract Refract Surg 2012; 38: 1072-1076
- 155 Vimalin J, Gupta N, Jambulingam M. et al. The effect of riboflavin-UV-A treatment on corneal limbal epithelial cells – a study on human cadaver eyes. Cornea 2012; 31: 1052-1059
- 156 Labiris G, Sideroudi H, Angelonias D. et al. Impact of corneal cross-linking combined with photorefractive keratectomy on blurring strength. Clin Ophthalmol 2016; 10: 571-576
- 157 Kozobolis V, Gkika M, Sideroudi H. et al. Effect of riboflavin/UVA collagen cross-linking on central cornea, limbus and intraocular pressure. experimental study in rabbit eyes. Acta Medica (Hradec Kralove) 2016; 59: 91-96
- 158 Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg 2009; 35: 588-589
- 159 Garcia-Delpech S, Díaz-Llopis M, Udaondo P. et al. Fusarium keratitis 3 weeks after healed corneal cross-linking. J Refract Surg 2010; 26: 994-995
- 160 Zamora KV, Males JJ. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea 2009; 28: 474-476
- 161 Kymionis GD, Portaliou DM, Bouzoukis DI. et al. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg 2007; 33: 1982-1984
- 162 Eberwein P, Auw-Hädrich C, Birnbaum F. et al. Hornhauteinschmelzung nach Cross-Linking und tiefer lamellärer Keratoplastik („DALK“) bei Keratokonus. Klin Monatsbl Augenheilkd 2008; 225: 96-98
- 163 Wollensak G, Spoerl E, Wilsch M. et al. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg 2003; 29: 1786-1790
- 164 Kymionis GD, Portaliou DM, Diakonis VF. et al. Corneal collagen cross-linking with riboflavin and ultraviolet-A irradiation in patients with thin corneas. Am J Ophthalmol 2012; 153: 24-28
- 165 Bagga B, Pahuja S, Murthy S. et al. Endothelial failure after collagen cross-linking with riboflavin and UV-A: case report with literature review. Cornea 2012; 31: 1197-1200
- 166 Sharma A, Nottage JM, Mirchia K. et al. Persistent corneal edema after collagen cross-linking for keratoconus. Am J Ophthalmol 2012; 154: 922-926.e1
- 167 Cagil N, Sarac O, Can GD. et al. Outcomes of corneal collagen crosslinking using a customized epithelial debridement technique in keratoconic eyes with thin corneas. Int Ophthalmol 2016; 37: 103-109
- 168 Lange C, Böhringer D, Reinhard T. Corneal endothelial loss after crosslinking with riboflavin and ultraviolet-A. Graefes Arch Clin Exp Ophthalmol 2012; 250: 1689-1691
- 169 Vinciguerra P, Camesasca FI, Romano MR. Corneal crosslinking and lens opacity. Ophthalmology 2011; 118: 2519.e1-e2
- 170 Goldich Y, Marcovich AL, Barkana Y. et al. Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus. Cornea 2010; 29: 409-411
- 171 Poli M, Cornut P-L, Balmitgere T. et al. Prospective study of corneal collagen cross-linking efficacy and tolerance in the treatment of keratoconus and corneal ectasia: 3-year results. Cornea 2013; 32: 583-590
- 172 Marino GK, Torricelli AAM, Giacomin N. et al. Accelerated corneal collagen cross-linking for postoperative LASIK ectasia: two-year outcomes. J Refract Surg 2015; 31: 380-384
- 173 Bamdad S, Sedaghat M, Bagheri M. et al. Changes in corneal topography and biomechanical properties after collagen cross linking for keratoconus: 1-year results. Middle East Afr J Ophthalmol 2015; 22: 212-219
- 174 Hayes S, Kamma-Lorger CS, Boote C. et al. The effect of riboflavin/UVA collagen cross-linking therapy on the structure and hydrodynamic behaviour of the ungulate and rabbit corneal stroma. PLoS One 2013; 8: e52860
- 175 Vetter JM, Brueckner S, Tubic-Grozdanis M. et al. Modulation of central corneal thickness by various riboflavin eyedrop compositions in porcine corneas. J Cataract Refract Surg 2012; 38: 525-532
- 176 Gokhale NS. Corneal endothelial damage after collagen cross-linking treatment. Cornea 2011; 30: 1495-1498
- 177 Richoz O, Schutz JS, Pajic B. et al. Crosslinking for recurrent keratoconus. Ophthalmology 2012; 119: 878-878.e2
- 178 Jordan C, Patel DV, Abeysekera N. et al. In vivo confocal microscopy analyses of corneal microstructural changes in a prospective study of collagen cross-linking in keratoconus. Ophthalmology 2014; 121: 469-474